Conditions: Adrenocortical Carcinoma; Adrenocortical Cancer
Intervention:
Sponsor: National Cancer Institute (NCI)
Recruiting
Feeds
24313 items (24313 unread) in 74 feeds
Acinar Cell Carcinoma
(192 unread)
Acinic Cell Carcinoma
(77 unread)
Adenoid Cystic Carcinoma
(484 unread)
Adrenal Gland Cancer
(2256 unread)
Ampulla Of Vater
(172 unread)
Anal Cancer
(2221 unread)
Angiosarcoma
(402 unread)
Appendix Cancer
(391 unread)
Bile Duct Cancer
(3623 unread)
Brain and CNS
(3048 unread)
Carcinoid
(784 unread)
Endocrine/Neuroendocrine
(2488 unread)
Gall Bladder Cancer
(1080 unread)
Hemangioendothelioma
(446 unread)
Hepatoblastoma
(332 unread)
Pancreas
(412 unread)
Phyllodes
(214 unread)
PMP and Mucinous Tumors
(149 unread)
Rhabdomyosarcoma
(785 unread)
Sarcoma
(4757 unread)
Trial - Adrenal Cancer (48 unread)
-
Natural History Study of Children and Adults With Adrenocortical Cancer (ACC)
Posted: June 25th, 2020, 2:00pm GMT
-
Inflammatory Effect Comparison Between Fentanyl and Remifentanil in Mastectomy Under General Anesthesia
Posted: June 17th, 2020, 2:00pm GMT
Conditions: Breast Disease; Anesthesia; Inflammatory Response
Interventions: Drug: Remifentanil; Drug: Fentanyl
Sponsor: Udayana University
Not yet recruiting -
Neuroendocrine and Adrenal Tumors
Posted: June 16th, 2020, 2:00pm GMT
Conditions: Neuroendocrine Tumors; Adrenal Tumor
Intervention: Other: No intervention
Sponsor: University of Pennsylvania
Not yet recruiting -
Predicting the Quality of Response to Specific Treatments in Patients With cGVHD, PQRST Study
Posted: June 16th, 2020, 2:00pm GMT
Condition: Chronic Graft Versus Host Disease
Interventions: Procedure: Biospecimen Collection; Other: Medical Chart Review; Other: Quality-of-Life Assessment; Other: Questionnaire Administration
Sponsors: Fred Hutchinson Cancer Research Center; National Cancer Institute (NCI)
Not yet recruiting -
SpotCheck: Comparison of Enhanced Telemedicine Versus In-person Evaluation for the Diagnosis of Skin Cancer
Posted: June 2nd, 2020, 2:00pm GMT
Condition: Skin Cancer
Interventions: Device: Nevisense 3.0; Device: Dermlite Cam; Procedure: Skin biopsy
Sponsor: NYU Langone Health
Not yet recruiting -
Effects of Adrenal Artery Ablation and Spironolactone in Patients With Primary Aldosteronism
Posted: June 1st, 2020, 2:00pm GMT
Conditions: Primary Aldosteronism; Hypertension
Intervention: Procedure: Endovascular chemical Ablation of Adrenal Gland
Sponsor: Third Military Medical University
Recruiting -
Trial of Cabozantinib Plus Atezolizumab in Advanced and Progressive Neoplasms of the Endocrine System. The CABATEN Study
Posted: May 25th, 2020, 2:00pm GMT
Conditions: Neuroendocrine Tumor; Anaplastic Thyroid Cancer; Adenocarcinoma; Pheochromocytoma; Paraganglioma
Intervention: Drug: Cabozantinib 40 mg
Sponsors: Grupo Espanol de Tumores Neuroendocrinos; Ipsen; Roche Pharma AG
Not yet recruiting -
Testing the Addition of an Anticancer Drug, Olaparib, to the Usual Chemotherapy (Temozolomide) for Advanced Neuroendocrine Cancer
Posted: May 20th, 2020, 2:00pm GMT
Conditions: Advanced Adrenal Gland Pheochromocytoma; Advanced Paraganglioma; Metastatic Adrenal Gland Pheochromocytoma; Metastatic Paraganglioma; Unresectable Adrenal Gland Pheochromocytoma; Unresectable Paraganglioma
Interventions: Drug: Olaparib; Other: Quality-of-Life Assessment; Drug: Temozolomide
Sponsor: National Cancer Institute (NCI)
Not yet recruiting -
Effects of Pre-emptive Scalp Infiltration With Low-dose Ketorolac and Ropivacaine for Postoperative Pain
Posted: May 8th, 2020, 2:00pm GMT
Conditions: Pain; Supratentorial Brain Tumor
Interventions: Drug: Ketorolac; Drug: Ropivacaine; Drug: Epinephrine
Sponsor: Beijing Tiantan Hospital
Not yet recruiting -
Clinical Study on Circadian Genes Dysregulation in Patients With Glucocorticoid Disorders
Posted: May 5th, 2020, 2:00pm GMT
Conditions: Cushing Syndrome; Adrenal Insufficiency; Cushing Disease; Addison Disease
Intervention: Diagnostic Test: circadian gene expression evaluation
Sponsor: University of Roma La Sapienza
Recruiting -
the Effect of Dexmedetomidine and Magnesium Sulfate in Open Resection of Pheochromocytoma
Posted: March 25th, 2020, 2:00pm GMT
Condition: Pheochromocytoma
Interventions: Drug: Dexmedetomidine; Drug: General anesthetic
Sponsor: National Cancer Institute, Egypt
Recruiting -
Application of Rectus Sheath Block based-on Incision in Upper Abdominal Surgery
Posted: March 12th, 2020, 2:00pm GMT
Condition: Opioid Consumption
Interventions: Procedure: Subcostal TAP; Procedure: Modified RSB; Other: General anesthesia
Sponsor: The First Affiliated Hospital of Anhui Medical University
Recruiting -
Test Up Now Education Program
Posted: March 11th, 2020, 2:00pm GMT
Condition: Colorectal Cancer Screening
Interventions: Behavioral: Community Health Advisor; Behavioral: Usual care
Sponsors: Florida A&M University; National Institute on Minority Health and Health Disparities (NIMHD)
Not yet recruiting -
Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial
Posted: February 26th, 2020, 3:00pm GMT
Conditions: Ectomesenchymoma; Recurrent Adrenal Gland Pheochromocytoma; Recurrent Ependymoma; Recurrent Ewing Sarcoma; Recurrent Hepatoblastoma; Recurrent Langerhans Cell Histiocytosis; Recurrent Malignant Germ Cell Tumor; Recurrent Malignant Glioma; Recurrent Medulloblastoma; Recurrent Melanoma; Recurrent Neuroblastoma; Recurrent Non-Hodgkin Lymphoma; Recurrent Osteosarcoma; Recurrent Peripheral Primitive Neuroectodermal Tumor; Recurrent Rhabdoid Tumor; Recurrent Rhabdoid Tumor of the Kidney; Recurrent Rhabdomyosarcoma; Recurrent Soft Tissue Sarcoma; Recurrent Thyroid Gland Carcinoma; Recurrent WHO Grade II Glioma; Refractory Adrenal Gland Pheochromocytoma; Refractory Ependymoma; Refractory Ewing Sarcoma; Refractory Hepatoblastoma; Refractory Langerhans Cell Histiocytosis; Refractory Malignant Germ Cell Tumor; Refractory Malignant Glioma; Refractory Medulloblastoma; Refractory Melanoma; Refractory Neuroblastoma; Refractory Non-Hodgkin Lymphoma; Refractory Osteosarcoma; Refractory Peripheral Primitive Neuroectodermal Tumor; Refractory Rhabdoid Tumor; Refractory Rhabdoid Tumor of the Kidney; Refractory Rhabdomyosarcoma; Refractory Soft Tissue Sarcoma; Refractory Thyroid Gland Carcinoma; Refractory WHO Grade II Glioma; Wilms Tumor
Intervention: Drug: Tipifarnib
Sponsor: National Cancer Institute (NCI)
Not yet recruiting -
RAMPS VS SRPS for Pancreatic Body and Tail Adenocarcinoma
Posted: February 5th, 2020, 3:00pm GMT
Condition: Radical Antegrade Modular Pancreatosplenectomy
Interventions: Procedure: Radical antegrade modular pancreatosplenectomy; Procedure: Standard retrograde pancreatosplenectomy
Sponsor: Ruijin Hospital
Not yet recruiting -
Biological Effect of Vitamin D in Patients With Urothelial Carcinoma
Posted: December 12th, 2019, 3:00pm GMT
Condition: Urothelial Carcinoma
Intervention: Drug: Vitamin D
Sponsors: Germans Trias i Pujol Hospital; Spanish Clinical Research Network - CAIBER; Centro Nacional de Investigaciones Oncologicas CARLOS III; Fundació Institut Germans Trias i Pujol
Recruiting -
Study of ASP1948, Targeting an Immune Modulatory Receptor, in Japanese Patients With Advanced Solid Tumors
Posted: September 19th, 2019, 2:00pm GMT
Condition: Locally Advanced (Unresectable) or Metastatic Solid Tumor Malignancies
Intervention: Drug: ASP1948
Sponsor: Astellas Pharma Inc
Recruiting -
Biological Response to Brief Psychological Challenge
Posted: September 4th, 2019, 2:00pm GMT
Condition: Acute Inflammatory Response to Psychological Stress
Interventions: Behavioral: Socio-evaluative speech task, then Control; Behavioral: Control, then Socio-evaluative speech task
Sponsors: University of Pittsburgh; National Institute of Mental Health (NIMH)
Recruiting -
Dose-Escalation and Efficacy Study of LAE001/Prednisone Plus Afuresertib Patients With m-CRPC
Posted: August 19th, 2019, 2:00pm GMT
Condition: Metastatic Castration-resistant Prostate Cancer
Intervention: Drug: Phase I and Phase II: LAE001/prednisone + afuresertib
Sponsor: Laekna Limited
Recruiting -
Acute Effect of modeRate-intensity aerOBIc Exercise on Colon Cancer Cell Growth
Posted: August 15th, 2019, 2:00pm GMT
Conditions: Colon Adenocarcinoma; Colon Cancer
Intervention: Other: Exercise assessment
Sponsors: Northumbria University; York St John University; Newcastle University
Recruiting -
The Master Registry of Oncology Outcomes Associated With Testing and Treatment
Posted: July 22nd, 2019, 2:00pm GMT
Conditions: Adenocarcinoma; Adenocystic Carcinoma; Anal Cancer; Appendix Cancer; Brain Tumor; Glioblastoma; Astrocytoma; Bile Duct Cancer; Cholangiocarcinoma; Bladder Cancer; Bone Cancer; Synovial Sarcoma; Chondrosarcoma; Liposarcoma; Sarcoma, Kaposi; Sarcoma,Soft Tissue; Sarcoma; Osteosarcoma; CNS Cancer; Brain Stem Neoplasms; Breast Cancer; Cervical Cancer; Colorectal Cancer; Rectal Cancer; Colon Cancer; Esophageal Cancer; Esophagus Cancer; Cancer of Colon; Pancreatic Cancer; Cancer of Pancreas; Testis Cancer; Testicular Cancer; Ureter Cancer; Renal Cell Carcinoma; Kidney Cancer; Gestational Trophoblastic Tumor; Head and Neck Neoplasms; Parotid Tumor; Larynx Cancer; Tongue Cancer; Pharynx Cancer; Salivary Gland Cancer; Acute Myeloid Leukemia; Chronic Myeloid Leukemia; Acute Lymphoblastic Leukemia; Multiple Myeloma; Non Hodgkin Lymphoma; Carcinoid Tumor; Lung Cancer; Neuroendocrine Tumors; Mesothelioma; Thyroid Cancer; Parathyroid Neoplasms; Adrenal Cancer; Small Bowel Cancer; Stomach Cancer; Liver Cancer; Hepatic Cancer; Melanoma; Skin Cancer; Unknown Primary Tumors; Uterine Cancer; Fallopian Tube Cancer; Ovarian Cancer; Prostate Cancer; Vaginal Cancer; Penile Cancer; Vulvar Cancer; Waldenstrom Macroglobulinemia; Cancer, Advanced; Thymus Cancer; Nasopharyngeal Carcinoma; Multiple Endocrine Neoplasia; Pheochromocytoma; Small Cell Carcinoma; Pulmonary Carcinoma
Interventions: Diagnostic Test: Biomarker Testing (L); Drug: Systemic Treatment (T); Other: Patient Reported Outcomes (P)
Sponsor: Taproot Health
Not yet recruiting -
Paravertebral Block Versus Thoracic Epidural Analgesia
Posted: July 19th, 2019, 2:00pm GMT
Conditions: Lung Cancer; Postoperative Pain
Interventions: Drug: Thoracic epidural; Drug: Paravertebral block
Sponsor: St. Olavs Hospital
Recruiting -
Preoperative Regional Nerve Block for Acute and Chronic Post-Operative Pain Following Mastectomy
Posted: July 15th, 2019, 2:00pm GMT
Conditions: Breast Cancer; Mastectomy; Anesthesia, Local; Narcotic Use
Interventions: Drug: regional nerve block with local anesthesia of bupivacaine with steroid; Other: Placebo regional nerveblock with normal saline
Sponsor: University of Alabama at Birmingham
Not yet recruiting -
Serratus vs. Erector Spinae Fascial Plane Block for Breast and Axillary Surgery
Posted: June 7th, 2019, 2:00pm GMT
Conditions: Breast Cancer; Nerve Block; Regional Anesthesia; Neuromuscular Blockade
Interventions: Procedure: Serratus Block; Procedure: Erector spinae plane block
Sponsor: Women's College Hospital
Not yet recruiting -
AKT Inhibitor, Ipatasertib, With Endocrine and CDK 4/6 Inhibitor for Patients With Metastatic Breast Cancer (TAKTIC)
Posted: May 22nd, 2019, 2:00pm GMT
Condition: Breast Cancer
Interventions: Drug: Ipatasertib; Drug: Fulvestrant; Drug: Aromatase Inhibitor; Drug: Palbociclib
Sponsors: Massachusetts General Hospital; Genentech, Inc.
Recruiting -
Comparing the Efficacy of Local Anesthetics in Mohs Surgery
Posted: March 12th, 2019, 2:00pm GMT
Conditions: Lidocaine; Bupivacaine; Mohs Surgery; Anesthetic
Interventions: Drug: Lidocaine; Drug: Bupivacaine; Drug: Lidocaine and Bupivacaine
Sponsors: Ottawa Hospital Research Institute; Richard J. MacKay Endowment Fund; Benefactor Life Members’ Research Grant; The Ottawa Hospital Division of Dermatology
Recruiting -
Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic (1-3 Metastases) Cancer
Posted: March 5th, 2019, 3:00pm GMT
Condition: Metastatic Tumors
Interventions: Radiation: palliative radiotherapy; Radiation: Stereotactic ablative radiotherapy
Sponsors: British Columbia Cancer Agency; London Regional Cancer Program, Canada; Beatson Institute for Cancer Research, Scotland; The Alfred; Beacon Hospital, Ireland
Recruiting -
A Study of ASP1951 in Subjects With Advanced Solid Tumors
Posted: January 10th, 2019, 3:00pm GMT
Condition: Advanced Solid Tumors
Interventions: Drug: ASP1951; Drug: pembrolizumab
Sponsor: Astellas Pharma Global Development, Inc.
Recruiting -
MyVHL: Patient Natural History Study
Posted: November 21st, 2018, 3:00pm GMT
Conditions: Von Hippel-Lindau Disease; Hereditary Leiomyomatosis and Renal Cell Cancer; Birt-Hogg-Dube Syndrome; SDHB Gene Mutation
Intervention:
Sponsors: Ilene Sussman, PhD; National Organization for Rare Disorders
Recruiting -
Exparel and Marcaine for Pain Management in Thoracoscopic Lobectomy Patients
Posted: September 24th, 2018, 2:00pm GMT
Conditions: Non Small Cell Lung Cancer; Lung Cancer Stage 1
Interventions: Drug: Liposomal Bupivacaine; Drug: Bupivacaine-Epinephrine
Sponsor: Southern Illinois University
Recruiting -
A Phase 3 Comparison of Platinum-based Therapy With TSR-042 and Niraparib Versus Standard of Care (SOC) Platinum-based Therapy as First-line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer
Posted: July 27th, 2018, 2:00pm GMT
Conditions: Ovarian Neoplasms; Ovarian Cancer
Interventions: Drug: Niraparib; Drug: Dostarlimab (TSR-042); Drug: Placebo; Drug: Standard of care; Drug: Dostarlimab/Placebo; Drug: Niraparib/Placebo
Sponsors: Tesaro, Inc.; European Network of Gynaecological Oncological Trial Groups (ENGOT)
Recruiting -
Neoantigen DNA Vaccine in Combination With Nivolumab/Ipilimumab and PROSTVAC in Metastatic Hormone-Sensitive Prostate Cancer
Posted: May 22nd, 2018, 2:00pm GMT
Condition: Metastatic Hormone-Sensitive Prostate Cancer
Interventions: Biological: PROSTVAC-V; Biological: PROSTVAC-F; Drug: Nivolumab; Drug: Ipilimumab; Biological: Neoantigen DNA vaccine; Device: TriGrid Delivery System; Procedure: Tumor biopsy; Procedure: Peripheral blood; Procedure: Fecal samples; Procedure: Leukapheresis
Sponsors: Washington University School of Medicine; Bristol-Myers Squibb; Prostate Cancer Foundation; BJH Foundation
Recruiting -
Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks
Posted: December 15th, 2017, 3:00pm GMT
Conditions: Adrenal Gland Neoplasm; Hypertension; Bone Diseases, Metabolic; Cardiovascular Disease; Hyperinsulinemia
Intervention:
Sponsors: National Human Genome Research Institute (NHGRI); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting -
Cabozantinib in Treating Patients With Locally Advanced or Metastatic Unresectable Adrenocortical Carcinoma
Posted: December 12th, 2017, 3:00pm GMT
Conditions: Metastatic Carcinoma in the Adrenal Cortex; Stage III Adrenal Cortex Carcinoma AJCC v8; Stage IV Adrenal Cortex Carcinoma AJCC v8; Unresectable Adrenal Cortex Carcinoma
Interventions: Drug: Cabozantinib; Other: Pharmacogenomic Study; Other: Pharmacokinetic Study
Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI)
Recruiting -
Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors
Posted: November 7th, 2017, 3:00pm GMT
Conditions: Genitourinary Cancer; Adrenocortical Carcinoma; Non-urothelial Bladder; Non-urothelial Upper Tract; Penile Cancer; Non-adenocarcinoma Prostate Cancer; Refractory Germ-cell; High Grade Neuroendocrine Carcinoma/Small Cell Carcinoma
Interventions: Drug: Ipilimumab; Drug: Nivolumab
Sponsors: Dana-Farber Cancer Institute; Bristol-Myers Squibb
Recruiting -
Fecal Microbiota Transplantation in Depression
Posted: September 13th, 2017, 2:00pm GMT
Condition: Major Depressive Disorder
Interventions: Drug: Fecal microbiota capsules; Drug: Placebo oral capsule
Sponsor: Psychiatric Hospital of the University of Basel
Recruiting -
Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma
Posted: July 2nd, 2017, 2:00pm GMT
Conditions: Pheochromocytoma; Paraganglioma; Neuroendocrine Tumors; Neuroendocrine Neoplasms
Interventions: Drug: Lu-177-DOTATATE; Drug: Ga-68-DOTATATE; Drug: F-18-FDG; Drug: Amino Acid solution
Sponsor: National Cancer Institute (NCI)
Recruiting -
Propranolol Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery
Posted: May 15th, 2017, 2:00pm GMT
Condition: Prostate Carcinoma
Interventions: Other: Laboratory Biomarker Analysis; Drug: Propranolol Hydrochloride; Other: Questionnaire Administration; Other: Survey Administration
Sponsors: Wake Forest University Health Sciences; National Cancer Institute (NCI)
Recruiting -
Familial Investigations of Childhood Cancer Predisposition
Posted: February 10th, 2017, 3:00pm GMT
Conditions: Acute Leukemia; Adenomatous Polyposis; Adrenocortical Carcinoma; AML; BAP1 Tumor Predisposition Syndrome; Carney Complex; Choroid Plexus Carcinoma; Constitutional Mismatch Repair Deficiency Syndrome; Diamond-Blackfan Anemia; DICER1 Syndrome; Dyskeratosis Congenita; Emberger Syndrome; Familial Acute Myeloid Leukemia; Familial Adenomatous Polyposis; Fanconi Anemia; Familial Cancer; Familial Wilms Tumor; Familial Neuroblastoma; GIST; Hereditary Breast and Ovarian Cancer; Hereditary Paraganglioma-Pheochromocytoma Syndrome; Hodgkin Lymphoma; Juvenile Polyposis; Li-Fraumeni Syndrome; Lynch Syndrome; MDS; Melanoma Syndrome; Multiple Endocrine Neoplasia Type 1; Multiple Endocrine Neoplasia Type 2; Neuroblastoma; Neurofibromatosis Type 1; Neurofibromatosis Type II; Nevoid Basal Cell Carcinoma Syndrome; Non Hodgkin Lymphoma; Noonan Syndrome and Other Rasopathy; Overgrowth Syndromes; Pancreatic Cancer; Peutz-Jeghers Syndrome; Pheochromocytoma/Paraganglioma; PTEN Hamartoma Tumor Syndrome; Retinoblastoma; Rhabdoid Tumor Predisposition Syndrome; Rhabdomyosarcoma; Rothmund-Thomson Syndrome; Tuberous Sclerosis; Von Hippel-Lindau Disease
Intervention:
Sponsor: St. Jude Children's Research Hospital
Recruiting -
Study of Biomarker-Based Treatment of Acute Myeloid Leukemia
Posted: January 9th, 2017, 3:00pm GMT
Condition: Previously Untreated Acute Myeloid Leukemia
Interventions: Biological: Samalizumab (BAML-16-001-S1); Biological: BI 836858 (BAML-16-001-S2); Other: Laboratory Biomarker Analysis; Drug: Daunorubicin (BAML-16-001-S1); Drug: Cytarabine (BAML-16-001-S1); Drug: Azacitidine (BAML-16-001-S2); Drug: AG-221 (BAML-16-001-S3); Drug: Azacitidine (BAML-16-001-S3); Drug: Entospletinib (BAML-16-001-S4); Drug: Azacitidine (BAML-16-001-S4); Drug: Entospletinib (BAML-16-001-S5); Drug: Decitabine (BAML-16-001-S5); Drug: Entospletinib (BAML-16-001-S6); Drug: Daunorubicin (BAML-16-001-S6); Drug: Cytarabine (BAML-16-001-S6); Drug: Pevonedistat (BAML-16-001-S9); Drug: Azacitidine (BAML-16-001-S9); Drug: AG-120 (BAML-16-001-S16); Drug: Azacitidine (BAML-16-001-S16); Drug: Gilteritinib (BAML-16-001-S8); Drug: Decitabine (BAML-16-001-S8)
Sponsor: Beat AML, LLC
Recruiting -
Renal Sympathetic Denervation From The Adventitia on Hypertension
Posted: December 30th, 2015, 3:00pm GMT
Condition: Primary Aldosteronism Due to Aldosterone Producing Adenoma
Intervention: Device: Renal Sympathetic Denervation
Sponsor: Henan Institute of Cardiovascular Epidemiology
Recruiting -
Exercise Intervention for LGBT Cancer Survivors
Posted: June 2nd, 2015, 2:00pm GMT
Condition: Neoplasms
Intervention: Behavioral: Exercise for Cancer Patients
Sponsor: University of Rochester
Recruiting -
Surgery of Subclinical Cortisol Secreting Adrenal Incidentalomas
Posted: February 16th, 2015, 3:00pm GMT
Condition: Adrenal Incidentalomas
Interventions: Procedure: Laparoscopic surgical removal of the adrenal tumor; Drug: Standardized medical treatment of hypertension by SAHR
Sponsor: University Hospital, Bordeaux
Recruiting -
Cabozantinib S-malate in Treating Patients With Metastatic Pheochromocytomas or Paragangliomas That Cannot Be Removed by Surgery
Posted: November 27th, 2014, 3:00pm GMT
Conditions: Locally Advanced Paraganglioma; Metastatic Adrenal Gland Pheochromocytoma; Metastatic Paraganglioma; Regional Adrenal Gland Pheochromocytoma; Unresectable Adrenal Gland Pheochromocytoma; Unresectable Paraganglioma
Interventions: Drug: Cabozantinib S-malate; Other: Laboratory Biomarker Analysis; Other: Questionnaire Administration
Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI)
Recruiting -
Natural History Study of Children and Adults With Medullary Thyroid Cancer
Posted: August 9th, 2012, 2:00pm GMT
Condition: Medullary Thyroid Carcer
Intervention:
Sponsor: National Cancer Institute (NCI)
Recruiting -
Adrenalectomy Versus Follow-up in Patients With Subclinical Cushings Syndrome
Posted: November 23rd, 2010, 3:00pm GMT
Condition: Adrenal Tumour With Mild Hypercortisolism
Intervention: Procedure: Adrenalectomy
Sponsor: Region Skane
Recruiting -
Molecular Characterization of Neuroblastic Tumor: Correlation With Clinical Outcome
Posted: January 8th, 2008, 3:00pm GMT
Condition: Neuroblastoma
Intervention: Other: Tumor and Marrow Markers
Sponsors: Memorial Sloan Kettering Cancer Center; Southern Illinois University; Spanish National Cancer Center; St. Jude Children's Research Hospital; Washington University School of Medicine; University of Texas; Weill Medical College of Cornell University
Recruiting -
Diagnosis of Pheochromocytoma
Posted: March 3rd, 2000, 3:00pm GMT
Conditions: Pheochromocytoma; Endocrine Disease; Endocrine Diseases
Interventions: Drug: ([18F]-DOPA); Drug: [68Ga]-DOTATATE; Drug: ([18F]-6F-DA)
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting